Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza
Creator
Thomsen, Reimar
Brun, Nikolai
Christensen, Steffen
Christiansen, Christian
Hallas, Jesper
Johansen, Nanna
Kristensen, Kasper
Lund, Lars
Pottegård, Anton
Reilev, Mette
Støvring, Henrik
Sørensen, Henrik
Thomsen, Marianne
Voldstedlund, Marianne
Source
Medline; PMC
abstract
IMPORTANCE: During the ongoing coronavirus disease 2019 pandemic, case reports have suggested that the use of nonsteroidal anti-inflammatory drugs (NSAIDs) may lead to adverse outcomes. OBJECTIVE: To study the association of NSAID use with adverse outcomes in patients hospitalized with influenza or influenza pneumonia. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used propensity score matching among 7747 individuals aged 40 years or older who were hospitalized with influenza, confirmed by polymerase chain reaction or antigen testing, between 2010 and 2018. Data were collected using Danish nationwide registers. All analyses reported were performed on May 29, 2020. EXPOSURES: Prescription fill of an NSAID within 60 days before admission. MAIN OUTCOMES AND MEASURES: Risk ratio (RR) and risk difference (RD) with 95% CIs for intensive care unit admission and death within 30 days of admission. RESULTS: A total of 7747 patients (median [interquartile range] age, 71 [59-80] years, 3980 [51.4%] men) with confirmed influenza were identified. Of these, 520 (6.7%) were exposed to NSAIDs. In the unmatched cohorts, 104 of 520 patients (20.0%) who used NSAIDs and 958 of 7227 patients (13.3%) who did not use NSAIDs were admitted to the intensive care unit. For death within 30 days of admission, we observed 37 events (7.1%) among those who used NSAIDs compared with 563 events (7.8%) among those who did not. Current NSAID use was associated with intensive care unit admission (RR, 1.51; 95% CI, 1.26 to 1.81; RD, 6.7%; 95% CI, 3.2% to 10.3%), while NSAID use was not associated with death (RR, 0.91; 95% CI, 0.66 to 1.26; RD, –0.7%; 95% CI, –3.0% to 1.6%). In the matched cohorts, risks were unchanged for patients who used NSAIDs, while 83 ICU admissions (16.0%) and 36 deaths (6.9%) were observed among matched individuals who did not use NSAIDs. Matched (ie, adjusted) analyses yielded attenuated risk estimates for intensive care unit admission (RR, 1.25; 95% CI, 0.95 to 1.63; RD, 4.0%; 95% CI, –0.6% to 8.7%) and death (RR, 1.03; 95% CI, 0.66 to 1.60; RD, 0.2%; 95% CI, –2.9% to 3.3%). Associations were more pronounced among patients who used NSAIDs for a longer period (eg, for intensive care unit admission: RR, 1.90; 95% CI, 1.19 to 3.06; RD, 13.4%; 95% CI, 4.0% to 22.8%). CONCLUSIONS AND RELEVANCE: In this cohort study of adult patients hospitalized with influenza, the use of NSAIDs was not associated with 30-day intensive care unit admission or death in adjusted analyses. There was an association between long-term use of NSAIDs and intensive care unit admission.
has issue date
2020-07-01
(
xsd:dateTime
)
bibo:doi
10.1001/jamanetworkopen.2020.13880
bibo:pmid
32609352
has license
cc-by
schema:url
https://doi.org/10.1001/jamanetworkopen.2020.13880
resource representing a document's title
Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza
has PubMed Central identifier
PMC7330719
has PubMed identifier
32609352
schema:publication
JAMA Netw Open
resource representing a document's body
covid:PMC7330719#body_text
is
schema:about
of
named entity 'ASSOCIATION'
named entity 'PATIENTS'
named entity 'Influenza'
named entity 'NSAIDs'
named entity 'outpatient'
named entity 'diclofenac'
named entity 'influenza'
named entity 'Civil Registration'
named entity 'ibuprofen'
named entity 'residual confounding'
named entity 'pathologies'
named entity 'pneumonia'
named entity '95% CI'
named entity '95% CI'
named entity 'influenza'
named entity 'International Classification of Diseases'
named entity 'benzodiazepine receptor'
named entity 'NSAIDs'
named entity 'NSAID'
named entity 'pharmacies'
named entity '95% CI'
named entity 'empyema'
named entity 'influenza'
named entity 'influenza'
named entity 'ICU'
named entity 'Patient Registry'
named entity 'acetaminophen'
named entity 'Anatomical'
named entity 'Danish'
named entity 'over-the-counter'
named entity 'Microbiology'
named entity 'polymerase chain reaction'
named entity 'Streptococcus pneumoniae'
named entity 'long-term'
named entity 'antigen'
named entity 'bacterial pneumonia'
named entity '95% CI'
named entity 'ICU'
named entity 'acetaminophen'
named entity 'NSAID'
named entity 'viral infections'
named entity 'NSAIDs'
named entity 'confounders'
named entity '95% CI'
named entity '95% CI'
named entity 'influenza'
named entity 'statistical significance'
named entity 'agonists'
named entity 'pneumonia'
named entity '95% CI'
named entity '95% CI'
named entity '95% CI'
named entity 'NSAIDs'
named entity '95% CI'
named entity 'antigen test'
named entity 'NSAIDs'
named entity 'treatment groups'
named entity '95% CI'
named entity 'ICD-10 code'
named entity 'Statistical analyses'
named entity 'antigen test'
named entity 'NSAIDs'
named entity '95% CI'
named entity 'NSAIDs'
named entity 'NSAID'
named entity 'over-the-counter'
named entity 'NSAIDs'
named entity '95% CI'
named entity '1.06'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software